Mount Sinai awarded three-year grant to explore therapeutic approaches to KRAS mutant lung tumors - EurekAlert

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a sign…

(New York, NY – August 9, 2022) Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic appr… [+7309 chars]

full article...